NYSE · Medical - Distribution

CAH (CAH) Stock

$239.35 +2.02% NYSE: CAH Healthcare

Valuation

MetricValue
Price$239.35
Market Cap$56.06B
P/E Ratio32.79
P/B Ratio-19.52
P/S Ratio0.22
EPS (TTM)$6.45
52-Week High$258.30
52-Week Low$145.87
Dividend Yield0.86%

Financials & Margins

MetricValue
ROE-59.73%
ROA2.99%
ROCE19.51%
Gross Margin3.68%
Operating Margin0.92%
Net Margin0.67%
Debt/Equity-3.45
Current Ratio0.94

Annual Financials (USD)

Metric20222023202420252026
Revenue$181.3B$205.0B$226.8B$222.6B$254.2B
Operating Profit$-607.0M$752.0M$1.2B$2.3B$2.6B
Net Profit$-938.0M$330.0M$852.0M$1.6B$1.7B
EPS$-3.34$1.26$3.45$6.45$7.23
Op Margin-0.3%0.4%0.6%1.0%1.0%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$43.9B$43.3B$45.1B$53.1B$57.3B
Total Liabilities$44.6B$46.3B$48.3B$55.8B$60.0B
Cash$4.7B$4.1B$5.1B$3.9B$4.9B
Borrowings$5.8B$5.2B$5.6B$9.3B$9.9B

Latest News

Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest? Zacks · Jul 10, 2026 Should You Retain CAH Stock After Removal From Several Russell Indices? Zacks · Jul 9, 2026 TD Cowen Adjusts Price Target on Cardinal Health to $275 From $255 MT Newswires · Jul 9, 2026 McKesson Stock Is Shrinking, and That's The Point for Owners Trefis · Jul 9, 2026 Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11 PR Newswire · Jul 9, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$3.1B$2.8B$3.8B$2.4B$5.2B
Investing Cash Flow$180.0M$-935.0M$-2.4B$-6.2B$-3.2B
Financing Cash Flow$-1.0B$-1.9B$-704.0M$-778.0M$-1.4B
Net Cash Flow$1.3B$-669.0M$1.1B$-1.3B$982.0M
Free Cash Flow$2.7B$2.4B$3.3B$1.9B$4.5B

Valuation & Return Ratios

MetricValue
PEG Ratio2.65
EV / EBITDA17.52
FCF Yield8.10%
Quick Ratio0.49
Interest Coverage7.51
Return 1Y58.51%
Return 3Y173.50%
Return 5Y329.68%

Ownership

Insiders Held0.26%
Institutions Held90.06%
Institutions Float Held90.29%
Institutional HolderSharesReport Date
Blackrock Inc.28,494,8552026-03-31
Vanguard Capital Management LLC15,288,7092026-03-31
Vanguard Portfolio Management LLC13,732,3092026-03-31
State Street Corporation12,074,5182026-03-31
Geode Capital Management, LLC6,580,5322026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
A $149.93 -2.36% 30.48 $42.35B 0.66%
ARGXargenx SE $862.93 +0.41% 48.25 $53.99B 0.00%
BDX $187.12 -0.53% 57.29 $51.56B 2.21%
BRKR $56.03 -3.41% 23.24 $8.53B 0.35%
COR $330.97 +2.28% 23.93 $64.39B 0.74%

About CAH

CAH is led by CEO Jason Hollar, employs 57,700 people, headquartered in Dublin, US, publicly traded since 1983.

CAH stock trades at $239.35 with a market capitalization of $56.06B. The stock is valued at a price-to-earnings (P/E) ratio of 32.79, price-to-book of -19.52, price-to-sales of 0.22. Over the past 52 weeks the stock has ranged between $145.87 and $258.30, and currently trades 7.3% below its 52-week high. It pays a dividend yielding 0.86%.

On profitability, CAH generates a return on equity (ROE) of -59.73%, return on capital employed of 19.51%, an operating margin of 0.92%, a net profit margin of 0.67%.

In its most recent fiscal year, CAH reported annual revenue of $254.2B, net profit of $1.7B, revenue has compounded at 9.4% a year over the last five years, profit at 22.9% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of -3.45 — a conservative balance sheet with little leverage risk, a current ratio of 0.94, total assets of $57.3B, $4.9B in cash and equivalents.

CAH has an average daily trading volume of 2,245,034 shares, a beta of 0.52 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides